Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bussel

Showing results (11-20 of 487) with videos related to

Pageof 49
Sort By:
Best Practice & Research. Clinical Haematology|December 3, 2014
The new thrombopoietic agenda: impact on leukemias and MDSJames B Bussel
Reviews of Infectious Diseases|May 1, 1990
Intravenous gammaglobulin in the prophylaxis of late sepsis in very-low-birth-weight infants: preliminary results of a randomized, double-blind, placebo-controlled trialJ B Bussel
Seminars in Hematology|February 28, 2009
The changing landscape of secondary ITP: introductionJames B Bussel
Hospital Practice (Office Ed.)|February 1, 1983
Circulating anticoagulants: physiologic and pathophysiologicJ B Bussel
The American Journal of Pediatric Hematology/Oncology|August 1, 1992
Familial thrombocytopenia with micromegakaryocytes: what is the defect in thrombopoiesis?J B Bussel
Hematology/Oncology Clinics of North America|February 1, 1990
Autoimmune thrombocytopenic purpuraJ B Bussel
New York State Journal of Medicine|August 1, 1985
Management of idiopathic thrombocytopenic purpura in childhoodJ B Bussel
Blood Reviews|March 27, 2002
Novel approaches to refractory immune thrombocytopenic purpuraJ B Bussel
American Journal of Hematology|October 17, 2020
Early combination treatment of immune thrombocytopenia: Is this the way?James B Bussel
Progress in Hemostasis and Thrombosis|January 1, 1986
Intravenous immunoglobulin therapy for the treatment of idiopathic thrombocytopenic purpuraJ B Bussel
Pageof 49

Showing results (11-20 of 487) with videos related to

Sort By:
Pageof 49
Best Practice & Research. Clinical Haematology|December 3, 2014
The new thrombopoietic agenda: impact on leukemias and MDSJames B Bussel
Reviews of Infectious Diseases|May 1, 1990
Intravenous gammaglobulin in the prophylaxis of late sepsis in very-low-birth-weight infants: preliminary results of a randomized, double-blind, placebo-controlled trialJ B Bussel
Seminars in Hematology|February 28, 2009
The changing landscape of secondary ITP: introductionJames B Bussel
Hospital Practice (Office Ed.)|February 1, 1983
Circulating anticoagulants: physiologic and pathophysiologicJ B Bussel
The American Journal of Pediatric Hematology/Oncology|August 1, 1992
Familial thrombocytopenia with micromegakaryocytes: what is the defect in thrombopoiesis?J B Bussel
Hematology/Oncology Clinics of North America|February 1, 1990
Autoimmune thrombocytopenic purpuraJ B Bussel
New York State Journal of Medicine|August 1, 1985
Management of idiopathic thrombocytopenic purpura in childhoodJ B Bussel
Blood Reviews|March 27, 2002
Novel approaches to refractory immune thrombocytopenic purpuraJ B Bussel
American Journal of Hematology|October 17, 2020
Early combination treatment of immune thrombocytopenia: Is this the way?James B Bussel
Progress in Hemostasis and Thrombosis|January 1, 1986
Intravenous immunoglobulin therapy for the treatment of idiopathic thrombocytopenic purpuraJ B Bussel
Pageof 49